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siologic in most cases. Nevertheless, very frequent isolated PVCs may lead to the development of a usually reversible 
left ventricular dysfunction or be a manifestation of an underlying cardiac condition that could be associated with more 
severe ventricular arrhythmias, heart failure or cardiac death.
Three causative mechanisms of the PVCs have been proposed: abnormal automaticity, triggered activity and reentry 
like palpitations, fatigue, dyspnoea or dizziness of a variable degree.
mechanisms should be pursued to establish the convenience of a conservative or therapeutic approach. 
who develop related systolic dysfunction or other kind of complications.
Premature ventricular complexes (PVCs), also known 
as premature ventricular contractions, ventricular pre-
mature beats or ventricular extrasystoles, can be defi-
ned as any cardiac single depolarization originated 
below the atrioventricular node, either in His-Purkinje 
tissue or in ventricular myocytes. They represent the 
most common ventricular arrhythmia and are frequently 
observed even in healthy individuals. Global prevalen-
ce varies between 1% to 4% on simple ECG and 40% 
to 75% on a 24 or 48-hour Holter monitoring.
Some risk factors for the appearance of PVCs are male 
gender, African-American ethnicity, hypertension and 
advanced age, showing an exponential increase in pre-
valence after the third or fourth decade of life (1–3).
Aetiology
Most frequently, PVCs have an idiopathic origin, not 
associated with any underlying cardiac disease, and 
arise mainly from some specific ventricular areas, be-
ing particularly common in the right ventricular out-
flow tract (RVOT) remaining unclear the reason for 
this preferential location. Other prevalent foci are the 
left ventricular outflow tract (LVOT), the aortic sinus of 
Valsalva, the atrioventricular valve annulus, the Pur-
kinje fibres or the papillary muscles. Idiopathic PVCs 
can appear spontaneously or favoured by increased 
sympathetic tone in situations such as anxiety, sleep 
deprivation, physical exercise, electrolyte disturban-
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ces and intake of drugs like cocaine, caffeine, alcohol 
or tobacco (4).
In some occasions PVCs may be related to an under-
lying cardiac condition, either affecting the electrical 
properties of the heart such as Brugada or long QT 
syndromes or being linked  to structural heart disea-
se (SHD) like hypertrophic or dilated cardiomyopathy, 
ischaemic heart disease, mitral valve prolapse… imply-
ing a poorer prognosis (5, 6).
Mechanisms
The pathophysiology of this phenomenon remains not 
totally clarified. Three possible mechanisms have been 
proposed (6, 7).
It consists in the spontaneous progressive depolarisa-
tion of the resting membrane potential (phase 4 of the 
action potential) until it finally reaches the electrical 
threshold and initiates a new action potential.
It is mainly observed in cells of the specialised conduc-
tion system but also occasionally in normal myocytes 
from certain regions like the outflow tract and it may be 
enhanced by several factors like increased sympathetic 
tone, use of inotropic agents, electrolyte disbalances or 
ischaemic states (6).
One phenomenon explained by this mechanism is pa-
rasystole in which a group of cells turns into an inde-
pendent focus firing at a rate that is typically unaffected 
by the electrical activity of the rest of the myocardium, 
linked to a functional unidirectional block that protects 
the parasystolic focus (8, 9).
Here, impulse formation results as a consequence of 
oscillations in the membrane potential related to the 
previous action potential (afterdepolarisations) which, if 
they are of sufficient amplitude, can trigger a new acti-
on potential.
Based on their temporal relationship, afterdepolarisa-
tions are classified as early (if they happen in phase 2 
or 3 of the action potential) or delayed (phase 4) (6, 7).
• Early afterdepolarisations occurring during phase 
2 are related to persistent inward calcium currents 
through ICa-L channels (10) and those in phase 
3 are mainly associated with IK1 channels (11). In 
both cases, action potential prolongation is the 
main predisposing condition that is manifested on 
surface ECG with a prolonged QT interval. Resul-
ting PVCs may induce polymorphic ventricular ta-
chycardia (VT) or torsades de pointes particularly 
in patients affected with long QT syndromes (12).
• Delayed afterdepolarisations occur in phase 4 as 
a result of an intracellular calcium overload initialy-
ly from extracellular source and then from additional 
calcium release from sarcoplasmic reticulum via rya-
nodine receptors. The increased intracellular con-
centration of calcium activates the Na-Ca exchan-
ger that can finally trigger a new action potential (13).
This mechanism is favoured by increased sympathetic 
tone and also by some drugs like digitalis (first drug in 
which this effect was observed) (14) or catecholamines.
It is considered the most common mechanism of PVCs 
in patients with no SHD, associated generally with a be-
nign course but also involved in possible malignant ar-
rhythmias like in patients with catecholaminergic poly-
morphic ventricular tachycardia syndrome (6).
In this mechanism the electrical impulse propagates 
around a circuit enclosed by functional or physical bar-
riers (usually scars) of unexcitable tissue. Due to the 
different electrophysiological properties of the fibres 
along the circuit, we can simplify it as formed by two 
distinct pathways with different conduction velocities 
and refractoriness. In normal conditions, the electrical 
impulse enters the circuit through both pathways lead-
ing to a final collision of wavefronts and no arrhythmia 
is originated. Under certain circumstances, and mainly 
because of the difference in refractoriness, unidirecti-
onal block may happen in one of the pathways so that 
the wavefront transmitted along the other pathway can 
cross the usual region of collision of wavefronts, advan-
ce retrogradely through the first pathway and close the 
circuit if the area of block has recovered the excitability.
Reentry is the main mechanism for ventricular arrhyt-
hmias in patients with SHD, most typically involved in 
sustained VT but also possible for single PVCs (6, 7, 
15, 16).
Clinical Presentation
There can be a wide variety of symptoms related to the 
presence of PVCs ranging from patients completely 
asymptomatic to others with more severe or even di-
sabling symptoms.
The most common clinical presentation consists in pal-
pitations attributed to the abnormal heart contraction 
produced by the PVC itself, the compensatory pause 
and the consecutive hypercontractile beat or a combi-
nation of these. Frequently, the patients describe the-
se palpitations either as irregular heart rhythm with the 
sensation of the heart skipping a beat or as pulsations 
in the neck in relation to cannon atrial waves that can 
be noticed also in the physical examination.
Some patients may experience light-headedness or 
presyncope in relation to ventricular bigeminy especi-
ally if the PVC shows a short coupling interval with the 
preceding beat resulting in insufficient ventricular filling 
and consequently ineffective contraction of the PVC 
leading to a functional relative bradycardia (6).
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Other possible symptoms could be chest discomfort, 
dyspnoea, exertional limitation or even overt heart failu-
re particularly in those patients with very frequent PVCs 
who can develop ventricular systolic dysfunction. This 
condition called PVC induced cardiomyopathy (PIC) is 
generally reversible following the reduction of the PVC 
burden after adequate treatment (17).
If the PVCs are associated with another heart conditi-
on there can be specific symptoms related to the latter, 
for instance chest pain in patients with ischaemic heart 
disease.
Malignant arrhythmias or sudden cardiac death (SCD) 
have also been reported even in the absence of any 
other apparent heart disease (although exceptional in 
these cases), happening mainly when PVCs present 
with short coupling intervals (18).
Evaluation
ECG
Initial diagnostic evaluation usually starts with a resting 
12-lead ECG showing one or more PVCs, sometimes 
as an incidental finding in a routine physical examina-
tion. On other occasions PVCs are discovered on a 
Holter monitoring during the investigation of the symp-
toms of the patient.
In any case, following the anamnesis about the clinical 
and family history of the patient, the first step should be 
a thorough analysis of the resting ECG looking for clues 
of a possible underlying substrate.
Then, if the PVC is visible on the ECG, we must try to 
identify its site of origin as this could have diagnostic, 
therapeutical and prognostic implications. Many diffe-
rent algorithms have been proposed for this matter.
In general terms, when the PVC presents with a right 
bundle branch block (RBBB) pattern in lead V1 the site 
of origin is very likely to be in the left ventricle whereas 
a left bundle branch block (LBBB) morphology in V1 
suggests an origin in the right ventricle or interventri-
cular septum.
Secondly, the inferior or superior direction of the PVC 
axis would point to an origin in the superior or inferior 
aspect of the ventricle respectively.
Thirdly, a QS pattern in lead V6 suggests a PVC origin 
near the apex as this lead is anatomically positioned 
close to this region. Conversely, positive wave in V6 
would suggest the base as the origin of the PVC and 
intermediate patterns would reflect base-to-apex inter-
mediate locations.
Another key aspect is the total QRS duration. Re-
latively narrow QRS generally indicates septal origin or 
early entry to the preferential conduction fibres of the 
His-Purkinje system.
Finally, signs of initial slow depolarisation would sug-
FIGURE 1. PVC with origin in RVOT. LEFT PANEL: Typical ECG pattern with tall R waves in the inferior leads and LBBB morpho-
logy with late precordial transition. Below the ECG, mapping catheter electrograms showing early activity and QS pattern in 
the unipolar configuration. These signals are compatible with the catheter being located on the site of origin of the PVC. RIGHT 
PANEL: 3D electroanatomic map confirming earliest activation area on the anterior wall of the RVOT
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gest an epicardial origin instead of the most common 
endocardial origin of the PVC (19).
Globally, the most frequent location of PVCs is the 
RVOT, generally not related to any underlying cardiac 
disease. Analysis of the morphology of these PVCs de-
serves special attention. The typical pattern consists of 
tall R waves in the inferior leads with an LBBB pattern in 
V1 with precordial transition happening after V3 
1). If precordial transition occurs before V3, the origin is 
more likely to be in the LVOT or within the aortic root on 
the right or left coronary cusps. When precordial transi-
tion occurs at V3, the site of origin is more unpredictable 
and may be either right or left sided.
During assessment of patients with PVCs, it is of para-
mount importance to determine the PVC burden, defi-
ned as the number of PVCs per day or as the percenta-
ge in relation to the total number of heart beats, which 
is ultimately related to the risk of developing PIC. Other 
important factors to analyse are the number of diffe-
rent PVC morphologies, if one or more morphologies 
are predominant, if there are only isolated PVCs or they 
group in couplets or even VT and if there is clinical cor-
relation between the presence of PVCs and the symp-
toms of the patient.
For these purposes, an ECG monitoring for a minimum 
of 24-hours would be advisable for all patients under 
investigation for PVCs.
Taking into account that PVC burden may be variable 
one day from another, mobile telemetry for a period of 7 
days may reflect the overall PVC burden more accura-
tely. Further than that, monitoring for 2 weeks or longer 
would provide little additional information (20).
Although most of the times PVCs have an idiopathic 
origin, they may sometimes be associated with under-
lying SHD, with a poorer prognosis and would warrant 
a specific treatment. Consequently, investigation with 
cardiac imaging techniques is usually required.
These imaging tests however might be unnecessary 
if there is no evidence of high PVC burden, patient is 
other wise healthy and physically active, no history of 
syncope or symptoms compatible with VT, no family 
history of early or sudden death or cardiomyopathy, and 
neither the resting ECG nor physical examination sug-
gest the presence of other abnormalities (6).
Transthoracic echocardiography (TTE) is the preferable 
initial imaging modality for both screening for SHD and 
evaluation of possible PIC in patients with high PVC 
burden (6). When conventional TTE is non-diagnostic 
but suspicion of possible SHD remains, additional tech-
niques like myocardial strain, transoesophageal echo-
cardiography and particularly cardiac magnetic reso-
nance imaging (MRI) may be necessary.
Thanks to its high resolution and sensitivity for iden-
tification of early stages of SHD and the possibility of 
scar analysis, cardiac MRI plays a key role in unco-
vering undiagnosed cardiac structural abnormalities 
even in those patients with previously presumed idio-
pathic PVCs. Several studies have indeed demonstra-
ted that routine diagnostic tests could be suboptimal, 
enhancing the role of cardiac MRI. Specific findings 
that suggest arrhythmogenic substrates are: late 
gadolinium enhancement, myocardial oedema, fatty 
infiltration or altered T1 mapping and increased extra-
cellular volume (21, 22).
Cardiac MRI should therefore be considered in situations 
that have proven a positive connection with underlying 
SHD like the presence of multifocal PVCs, induction of 
PVCs or more complex ventricular arrhythmias during 
exercise, PVCs with a non-LBBB inferior axis morpho-
logy or clinical factors like male gender, advanced age 
or family history of SCD or cardiomyopathy (22).
Exercise testing should be taken into consideration in 
those patients with PVCs which occur or worsen during 
exertion. It can also be used as a tool to add diagnos-
tic and prognostic values. The appearance of PVCs or 
even VT during exercise is more frequent in individuals 
with SHD, fact that implies a worse prognosis and a 
need for deeper evaluation.
In a study with otherwise apparently healthy athletes, 
those with repetitive PVCs during exercise were found 
to represent a high-risk subgroup and the presence of 
exercise-induced non-sustained polymorphic VT was 
associated with a probability of an underlying LV scar of 
67% (22, 23). Anyway, patients with idiopathic PVCs who 
develop monomorphic VT during exercise testing are still 
considered to have good prognosis, but a thorough in-
vestigation is necessary to ensure its benign nature (24).
It may serve to determine the mechanism and origin 
of the PVCs which can later be used to plan proper 
treatment, sometimes even catheter ablation during the 
same procedure.
In terms of the mechanisms, PVCs mediated by reentry 
are generally easily inducible by programmed stimula-
tion. Conversely, induction of PVCs mediated by trigge-
red activity or abnormal automaticity is more unpredic-
table, responding to the use of sympathomimetic drugs 
or to atrial or ventricular burst pacing with variable suc-
cess rates (25). 
During the EPS, the site of origin of the PVCs can be 
identified as the area with the earliest activation time 
or alternatively through pace mapping manoeuvres in 
cases of non-inducibility (26).
The creation of voltage maps depicting areas of scar 
tissue can also be useful since these zones are usually 
linked to sites of origin of ventricular arrhythmias in pa-
tients with SHD.
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Management
Specific treatment to reduce PVC burden will be ne-
cessary in symptomatic patients or in those who de-
velop PIC as this condition is generally reversible after 
adequate control of PVCs. In addition, some patients 
diagnosed of idiopathic dilated cardiomyopathy with 
impaired systolic function and a high PVC burden may 
have a certain component of PIC. It has been reported 
that some of these patients experience a significant 
improvement in ventricular contraction and volumes 
after successful reduction of their PVC burden, parti-
cularly in the ones with a ventricular dysfunction that 
is out of proportion in relation to the degree of myocar-
dial fibrosis detected in cardiac MRI (17).
Another situation in which treatment of PVCs should be 
pursued is in cases where PVCs are followed by initi-
ation of malignant ventricular arrhythmias. Successful 
ablation of these PVCs can lead to a decrease of the 
risk of ICD shocks (1).
Abuse of caffeine, theine, alcohol, tobacco or illicit drugs 
as well as high levels of stress and anxiety have been 
related to a higher risk of PVCs. Nevertheless, a rando-
mized trial evaluating PVC burden after total abstinence 
of caffeine, smoking and reduced alcohol intake in heal-
thy individuals failed to demonstrate a reduction of total 
PVCs (27). Since SHD patients were not investigated, 
further studies are needed to evaluate the potential be-
nefit of lifestyle modifications in this population.
Low blood levels of potassium and magnesium can fa-
vour the development of PVCs or other types of atrial 
and ventricular arrhythmias. A blood test for determi-
ning electrolyte levels is mandatory in these patients and 
prompt correction of hypokalaemia or hypomagnesemia 
as well as their possible causes would be necessary. 
Beta-blockers and non-dihydropyridine calcium channel 
blockers remain first-line pharmacological therapy for pa-
tients with frequent and symptomatic PVCs. A favourab-
le safety profile and the added benefit of beta-blockers in 
patients with ischaemic heart disease or with heart failu-
re with reduced ejection fraction make them the best ini-
tial medical therapy. Nevertheless, several studies have 
showed only a slight reduction (between 12 and 24%) of 
PVC burden in patients with symptomatic outflow tract 
PVCs treated with these agents (6).
If these drugs were ineffective or poorly tolerated, cat-
heter ablation should be the next therapeutical option. 
Anyway, other antiarrhythmic drugs could be regarded 
in those with a failed ablation or preference for medical 
treatment. Some of these antiarrhythmic drugs could 
be amiodarone (70% efficacy rate, although concerns 
about side effects in long-term treatment may limit its 
use) or sotalol (particularly in ischaemic heart disease 
patients). Flecainide and propafenone are other possib-
le options provided that SHD has been ruled out as they 
were associated with a higher mortality rate in this pati-
ent population (6, 28).
Catheter ablation is the preferable treatment if medical 
therapy is not tolerated, not effective or rejected by the 
patient. It has indeed a higher success rate (up to 80-
95%) and low incidence of complications (0-5%), mostly 
related to vascular access. Success rate diminishes in 
cases of non-inducibility during the procedure, presen-
ce of polymorphic PVCs or if the sites of origin of the 
PVCs are of difficult access like epicardial foci or loca-
ted in areas where catheter contact is more unstable 
or close to important anatomical structures (17, 29). In 
these latter circumstances use of imaging techniques 
such as intracardiac echocardiography, computed to-
mography, MRI or angiography may facilitate the abla-
tion procedure .
Follow up
Although, as previously mentioned, isolated PVCs are 
often thought to have minimal clinical significance in 
patients without SHD, persistence of high PVC burden 
may conduct to development of PIC in the long term, 
even if this condition is not present at the time of the 
initial evaluation. In spite that no clear cut-off value has 
been established, several studies have shown increa-
FIGURE 2. Image integration of 3D electroanatomic map 
and aortic angiography during catheter ablation of PVC 
arising from the aortic root. The visualisation of the origin 
of the coronary arteries provides safer guidance during the 
ablation procedure
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sing risk of development of PIC in accordance with the 
degree of PVC burden, being this risk of up to 40% in 
patients with a PVC burden greater than 10% and ex-
ceptional if PVC burden is below 6% (17). Therefore, 
annual echocardiogram is recommended in patients 
with high PVC burden and medical or ablative therapy 
should be reconsidered in case of progression to sys-
tolic dysfunction.
In addition to the degree of PVC burden, other factors 
that have been proposed as risk predictors of systolic 
coupling interval of the PVCs (30). In the presence of 
these features a closer follow up could be convenient.
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